AAMI vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

AAMI

58.9
AI Score
VS
AAMI Wins

CNS

57.5
AI Score

Investment Advisor Scores

AAMI

59score
Recommendation
HOLD

CNS

58score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric AAMI CNS Winner
Revenue 352.10M 94.41M AAMI
Net Income 51.60M 29.96M AAMI
Net Margin 14.7% 31.7% CNS
Operating Income 74.30M 36.29M AAMI
ROA 6.0% 6.7% CNS
Total Assets 856.90M 450.12M AAMI

Relative Price Performance (Last 90 Days)

AAMI 1M: +3.5% · 3M: +18.5% CNS 1M: -5.7% · 3M: -12.2%

Current Technical Phase

AAMI

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.4% over 20 days), RSI 58

RSI (14): 58.1 · Price: $95.11

CNS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.5%), weak momentum, RSI 44

RSI (14): 44.2 · Price: $70.26

Fundamentals Snapshot

Metric AAMI CNS
Market Cap — —
Forward P/E 14.9 18.8
Trailing P/E 33.5 21.1
Revenue (TTM) — —
Revenue Growth 0.5% 0.1%
Gross Margin 0.4% 0.5%
Operating Margin 0.2% 0.3%
EPS 2.82 3.42
Dividend Yield 0.00% 0.04%

Frequently Asked Questions

Based on our detailed analysis, AAMI is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.